ARCHIVES

Signet Cell A Rising Trend In Patients Under Age 40

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

In Brief: Clarkson, Freireich Head AACR, ASCO; Oncology Nursing Society Membership Total Now 2,369

June 6, 1980

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

HEW Approves New Cancer Clinical Education Grants, Without Trainee Stipends ; $4 Million Available In ’75

April 26, 1974